课题基金 / 基金详情

New aminobenzimidazole antimalarial agents with a novel mechanism of action

New aminobenzimidazole antimalarial agents with a novel mechanism of action
具有新作用机制的新型氨基苯并咪唑抗疟药
批准号:
nhmrc : GNT1163235
负责人:
金额:
$76.75万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2019
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2019-01-01 至 --

项目摘要

项目成果

相关文献

中文摘要
翻译
疟疾是一种在全球造成重大负担和分布的疾病,包括在澳大利亚的北方邻国东帝汶、印度尼西亚和巴布亚新几内亚。在过去十年中,亚洲出现了对所有主要抗疟药物的耐药性,这意味着迫切需要具有独特作用机制的新抗疟药物。该项目旨在确定一类新的氨基苯并咪唑类抗疟药活性的新作用机制。
英文摘要
Malaria is a disease with a globally significant burden and distribution, including a presence in Australia’s northern neighbours East Timor, Indonesia and Papua New Guinea. Resistance to all major classes of antimalarial drugs has emerged in Asia in the last decade, meaning new antimalarials with unique mechanisms of action are urgently needed. This project seeks to identify the novel mechanism of action responsible for the activity of a new class of aminobenzimidazole antimalarials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文